Search

Your search keyword '"Edwards, Caitlin E."' showing total 34 results

Search Constraints

Start Over You searched for: Author "Edwards, Caitlin E." Remove constraint Author: "Edwards, Caitlin E."
34 results on '"Edwards, Caitlin E."'

Search Results

1. SARS-CoV-2 variant of concern fitness and adaptation in primary human airway epithelia

2. Norovirus

3. Contributors

7. A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice

8. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

10. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures

11. Progenitor identification and SARS-CoV-2 infection in human distal lung organoids

13. Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures

14. Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease

15. Chapter 43 - Norovirus

16. Pharmacokinetic-based failure of a detergent virucidal for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) nasal infections: A preclinical study and randomized controlled trial

17. Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease

18. SARS-CoV-2 infection of airway cells causes intense viral and cell shedding, two spreading mechanisms affected by IL-13

19. Pharmacokinetic‐based failure of a detergent virucidal for severe acute respiratory syndrome–coronavirus‐2 (SARS‐CoV‐2) nasal infections: A preclinical study and randomized controlled trial

20. Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spike glycoprotein

21. Thiol-based mucolytics exhibit antiviral activity against SARS-CoV-2 through allosteric disulfide disruption in the spike glycoprotein

22. Pharmacokinetic-based failure of a detergent virucidal for SARS-COV-2 nasal infections

23. SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

24. SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo

25. Progenitor identification and SARS-CoV-2 infection in long-term human distal lung organoid cultures

26. The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

27. The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies

28. A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures

29. Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spike glycoprotein.

30. Pharmacokinetic-based failure of a detergent virucidal for SARS-COV-2 nasal infections.

31. SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo .

32. Progenitor identification and SARS-CoV-2 infection in long-term human distal lung organoid cultures.

33. The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies.

34. A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures.

Catalog

Books, media, physical & digital resources